Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population - PubMed (original) (raw)
. 2015 Oct;45(10):1017-24.
doi: 10.1111/eci.12480. Epub 2015 Aug 26.
Affiliations
- PMID: 26081791
- DOI: 10.1111/eci.12480
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population
Christel H Kamani et al. Eur J Clin Invest. 2015 Oct.
Abstract
Backgound: Regular physical activity is recommended to lower low-density lipoprotein cholesterol (LDL-C) in a healthy population. Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) was shown to reduce (LDL-C) levels; however, the impact of physical exercise on PCSK9 levels remains unclear.
Materials and methods: We used data from 67 healthy hospital employees who participated in a 6-month intervention promoting active use of stairs instead of elevators during 3 months, followed by 3 months without recommendation. We confirmed the degree of physical activity with estimated aerobic capacity (VO2 max ) and measured serum PCSK9 levels at baseline, 3 and 6 month. Using a multilevel regression model, we analysed changes of PCSK9 levels over time adjusting for age, gender, aerobic capacity, baseline LDL-C, and LDL-C and body mass index (BMI) changes.
Results: At baseline, PCSK9 levels were associated with higher aerobic capacity (P-value = 0·024). At 3 months, we observed a significant decrease in mean PCSK9 levels from 403·6 to 324·3 ng/mL (P-value = 0·001), as well a significant decrease in mean LDL-C levels from 3·5 to 3·3 mM (P-value = 0·01). During this period, mean aerobic capacity (VO2 max ) increased from 37·0 to 40·4 mL/kg/min (P-value < 0·001). Physical activity was independently associated with a decrease in PCSK9 levels after adjustment for age, gender, baseline aerobic capacity, and LDL-C and BMI changes.
Conclusion: Daily physical activity at the work place is independently associated with a decrease in PCSK9 levels over time.
Keywords: Biomarkers; PCSK9; lifestyle intervention; lipids; physical exercise.
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.
Similar articles
- Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
Urban D, Pöss J, Böhm M, Laufs U. Urban D, et al. J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21. J Am Coll Cardiol. 2013. PMID: 23973703 Review. - Furin-cleaved proprotein convertase subtilisin/kexin type 9 (PCSK9) is active and modulates low density lipoprotein receptor and serum cholesterol levels.
Lipari MT, Li W, Moran P, Kong-Beltran M, Sai T, Lai J, Lin SJ, Kolumam G, Zavala-Solorio J, Izrael-Tomasevic A, Arnott D, Wang J, Peterson AS, Kirchhofer D. Lipari MT, et al. J Biol Chem. 2012 Dec 21;287(52):43482-91. doi: 10.1074/jbc.M112.380618. Epub 2012 Nov 7. J Biol Chem. 2012. PMID: 23135270 Free PMC article. - Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.
Ghosh M, Gälman C, Rudling M, Angelin B. Ghosh M, et al. J Lipid Res. 2015 Feb;56(2):463-9. doi: 10.1194/jlr.M055780. Epub 2014 Dec 22. J Lipid Res. 2015. PMID: 25535288 Free PMC article. - PCSK9 inhibition in LDL cholesterol reduction: genetics and therapeutic implications of very low plasma lipoprotein levels.
Marais AD, Kim JB, Wasserman SM, Lambert G. Marais AD, et al. Pharmacol Ther. 2015 Jan;145:58-66. doi: 10.1016/j.pharmthera.2014.07.004. Epub 2014 Jul 18. Pharmacol Ther. 2015. PMID: 25046268 Review.
Cited by
- The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-analysis.
Smart NA, Downes D, van der Touw T, Hada S, Dieberg G, Pearson MJ, Wolden M, King N, Goodman SPJ. Smart NA, et al. Sports Med. 2024 Sep 27. doi: 10.1007/s40279-024-02115-z. Online ahead of print. Sports Med. 2024. PMID: 39331324 - Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9.
Schlüter KD, Wolf A, Schreckenberg R. Schlüter KD, et al. Front Physiol. 2020 Dec 7;11:598649. doi: 10.3389/fphys.2020.598649. eCollection 2020. Front Physiol. 2020. PMID: 33364976 Free PMC article. Review. - Untypical Metabolic Adaptations in Spontaneously Hypertensive Rats to Free Running Wheel Activity Includes Uncoupling Protein-3 (UCP-3) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Expression.
Wolf A, Kutsche HS, Atmanspacher F, Karadedeli MS, Schreckenberg R, Schlüter KD. Wolf A, et al. Front Physiol. 2021 Mar 23;12:598723. doi: 10.3389/fphys.2021.598723. eCollection 2021. Front Physiol. 2021. PMID: 33833685 Free PMC article. - LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy.
Hamasaki M, Sakane N, Hara K, Kotani K. Hamasaki M, et al. J Clin Lab Anal. 2021 Nov;35(11):e24056. doi: 10.1002/jcla.24056. Epub 2021 Oct 15. J Clin Lab Anal. 2021. PMID: 34652028 Free PMC article. - The effect of resistance training on PCSK9 levels in patients undergoing cardiac rehabilitation after coronary artery bypass grafting: a randomized study.
Dwiputra B, Santoso A, Purwowiyoto BS, Radi B, Ambari AM. Dwiputra B, et al. BMC Cardiovasc Disord. 2023 Nov 9;23(1):549. doi: 10.1186/s12872-023-03571-7. BMC Cardiovasc Disord. 2023. PMID: 37946122 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous